Results 1 to 10 of about 36,146 (282)

Pipeline therapies for neovascular age related macular degeneration [PDF]

International Journal of Retina and Vitreous, 2021
Age related macular degeneration (AMD) is the most common cause of vision loss in the elderly population. Neovascular AMD comprises 10% of all cases and can lead to devastating visual loss due to choroidal neovascularization (CNV).
Sruthi Arepalli, Peter K. Kaiser
doaj   +3 more sources

Rhizobium radiobacter Endophthalmitis following Intravitreal Ranibizumab Injection [PDF]

Case Reports in Ophthalmology, 2012
We present the first reported case of acute endophthalmitis due to Rhizobium radiobacter after an intravitreal injection of ranibizumab for neovascular age-related macular degeneration.
Lavnish Joshi, Jiten Morarji, Oren Tomkins-Netzer, Sue Lightman, Simon R.J. Taylor   +4 more
doaj   +3 more sources

Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years. [PDF]

Ophthalmologica
Korobelnik JF, Chaudhary V, Mitchell P, Kang SW, Allmeier H, Lee J, Zhang X, Machewitz T, Bailey C.   +8 more
europepmc   +2 more sources

Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study

Health Technology Assessment, 2022
Background: Neovascular age-related macular degeneration is a leading cause of sight loss, and early detection and treatment is important. For patients with neovascular age-related macular degeneration in one eye, it is usual practice to monitor the ...
Katie Banister, Jonathan A Cook, Graham Scotland, Augusto Azuara-Blanco, Beatriz Goulão, Heinrich Heimann, Rodolfo Hernández, Ruth Hogg, Charlotte Kennedy, Sobha Sivaprasad, Craig Ramsay, Usha Chakravarthy   +11 more
doaj   +1 more source

Estimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in Australia by ranibizumab treatment. [PDF]

PLoS ONE, 2014
Intravitreal injections of anti-vascular endothelial growth factor agents, such as ranibizumab, have significantly improved the management of neovascular age-related macular degeneration. This study used patient-level simulation modelling to estimate the
Paul Mitchell, Neil Bressler, Quan V Doan, Chantal Dolan, Alberto Ferreira, Aaron Osborne, Elena Rochtchina, Mark Danese, Shoshana Colman, Tien Y Wong   +9 more
doaj   +1 more source

Novel approach to antiangiogenic factors in age-related macular degeneration therapy

Central European Journal of Immunology, 2022
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss among the population above 85 worldwide. There are two main types of AMD: neovascular and dry AMD.
Katarzyna Samelska, Magdalena Kupis, Justyna Izdebska, Anna Kaminska, Piotr Skopiński   +4 more
doaj   +1 more source

Bacillary Layer Detachment in Neovascular Age-Related Macular Degeneration: Case Series

Biomedicines, 2023
Purpose: This study seeks to report the clinical and multimodal imaging findings of eight eyes of seven patients with neovascular age-related macular degeneration (nAMD) who developed bacillary layer detachment (BALAD).
Filomena Palmieri, Saad Younis, Walid Raslan, Lorenzo Fabozzi   +3 more
doaj   +1 more source

Cost effectiveness of treatments for wet age-related macular degeneration [PDF]

, 2011
Age-related macular degeneration (AMD) is a leading cause of blindness in people aged >= 50 years. Wet AMD in particular has a major impact on patient quality of life and imposes substantial burdens on healthcare systems.
Annemans, Lieven, Gallagher, Meghan, Mitchell, Paul, Thomas, Simu, White, Richard   +4 more
core   +1 more source

Optical Coherence Tomography-Angiography of Different Choroidal Neovascularization Subtypes in Wet Age-related Macular Degeneration

Folia Medica, 2019
Age-related macular degeneration is a leading cause of irreversible vision loss in individuals over 55 years of age worldwide. Conventionally, it is divided into two subtypes – dry (non-neovascular) and wet (neovascular) form.
Stavrev Vladimir N., Sivkova Nelly P., Koleva-Georgieva Desislava N.   +2 more
doaj   +1 more source

New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium

International Journal of Retina and Vitreous, 2020
We summarize the most important findings presented at the 2020 angiogenesis, exudation and degeneration symposium in five topic areas: (1) epidemiology of retinal vascular disease and macular degeneration; (2) dry AMD and geographic atrophy; (3 ...
Carmen A. Puliafito, Charles C. Wykoff
doaj   +1 more source